Funding Archives – Page 2 of 2 – Treatment Action Group

Cover of Tuberculosis Research Funding Trends 2005-2018

2019 Report on TB Research Funding Trends

December 10, 2019
Dorrit Walsh

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.

Closing the Gap in Tuberculosis Research and Development Funding Briefs

February 20, 2019
Chad Cipiti

In our two briefs, Closing the Gap in Tuberculosis Research and Development Funding: Actions for U.S. Government Executive Agencies and Actions for U.S. Congress, we detail how a funding increase of 0.1 percent, based on "fair share" of research capacity, would close the funding gap in TB R&D, catalyze new public health tools we need to create positive health outcomes among communities vulnerable to TB worldwide.

Rapid Shift From Global To National Purchase of TB Drugs Increases Risk of Stockouts and Use of Drugs of Unknown Quality

October 26, 2018
Chad Cipiti

Global activists at the 49th Union Conference on Lung Health in The Hague opened up a pop-up TB drug warehouse to warn about the dire public health consequences of a rushed shift from Global Fund supported pooled procurement of tuberculosis (TB) drugs and other health products to domestic funding and national procurement systems.

Higher Funding for TB Research Signals Hope, but Governments Must Dramatically Increase Spending to End TB

November 8, 2017
Chad Cipiti

Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report released today by Treatment Action Group (TAG) and the United Nations–hosted Stop TB Partnership.

Tuberculosis Research at Risk as Big Pharma Shutters Programs

October 22, 2014
Chad Cipiti

Worldwide governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group.

First-Ever Targeted Roadmap Outlines Steps to End Childhood TB Deaths

October 1, 2013
Chad Cipiti

Cost to end deaths from childhood TB estimated to be at least US$120 million annually WASHINGTON D.C. | October 1, 2013 -- The deaths of more than 74 000 children from tuberculosis (TB) could be prevented each year through measures outlined…

Treatment Action Group and the Stop TB Partnership Issue Update on 2011 Global TB R&D Investment Trends

November 14, 2012
Chad Cipiti

For the seventh year, Treatment Action Group (TAG) and the Stop TB Partnership have published the latest investment data on the state of global tuberculosis (TB) research and development (R&D) funding.

Letter to President Obama on Proposed FY 2013 Budget Cut to PEPFAR

March 5, 2012
Chad Cipiti

As representatives of organizations that advocate for an evidence-based and robust response to global AIDS, we respond to your fiscal year 2013 budget request for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)—the flagship bilateral AIDS program—with shock and dismay.